ArticleAnnals of translational medicine2019
Deep neural networks could differentiate Bethesda class III versus class IV/V/VI.
Article in Annals of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Diagnostic Performance of Ultrasound vs Ultrasound-Guided FNAC in Thyroid Nodules: Data From the ElaTION Trial.The Journal of clinical endocrinology and metabolism · 2025Trial
- Automatic ganglion cell detection for improving the efficiency and accuracy of hirschprung disease diagnosis.Scientific reports · 2021Trial
- Review
- Perineural invasion detection in pancreatic ductal adenocarcinoma using artificial intelligence.Scientific reports · 2023Article
- Artificial intelligence in thyroid ultrasound.Frontiers in oncology · 2023Review
- Radiomic Detection of Malignancy within Thyroid Nodules Using Ultrasonography-A Systematic Review and Meta-Analysis.Diagnostics (Basel, Switzerland) · 2022Review
- Are the anatomical, clinical, and ultrasound characteristics of thyroid nodules with Bethesda III or IV cytology and ACR TI-RADS 3, 4, or 5 able to refine the indications for molecular diagnostic tests?Archives of endocrinology and metabolism · 2021Article
- Diagnosing thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance cytology with the deep convolutional neural network.Scientific reports · 2021Observational
- Technology trends and applications of deep learning in ultrasonography: image quality enhancement, diagnostic support, and improving workflow efficiency.Ultrasonography (Seoul, Korea) · 2021Article
- Telomerase reverse transcriptase promoter mutations in thyroid carcinomas: implications in precision oncology-a narrative review.Annals of translational medicine · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUltrasound (US) is the most commonly used radiologic modality to identify and characterize thyroid nodules. Many nodules subsequently undergo fine needle aspiration to further characterize the nodule and determine appropriate treatment. The fine needle aspirate is most commonly classified using the Bethesda System for Reporting Thyroid Cytology (TBSRTC). It can sometimes be difficult to differentiate Bethesda class III lesions (atypia of undetermined significance/follicular lesion of undetermined significance) from Bethesda class IV, V and VI (malignant nodules). However, differentiation is important as clinical management differs between the two groups. The purpose of this study was to introduce machine learning methods to help radiologists differentiate Bethesda class III from Bethesda class VI, V and VI lesions.
methodsThe authors collected 467 thyroid nodules with cytopathology results. US features were summarized using the 2017 ACR (American College of Radiology) Thyroid Imaging Reporting And Data System (TIRADS). Machine learning models [logistic regression, gradient boost, support vector machine (SVM), random forest and deep neural networks (DNN)] were created to classify Bethesda class III vs class IV/V/VI.
resultsDNN outperformed other machine learning classifiers and obtained the highest accuracy and specificity to classify thyroid nodules as either Bethesda III or IV/V/VI nodules using multiple US features.
conclusionsMachine learning/deep learning approaches could help differentiate Bethesda III nodules from IV/V/VI using US features which may benefit treatment decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.